1. TIDE: Tech Incubation Labs
Steve Woodward
Super Symposium 2017 June 2017
THE ART OF THE POSSIBLE
2. 2
TECHNOLOGY INCUBATION LAB
Drive Technology
Leadership
• Accelerate innovation
culture
• Support learning between
functional silos
• Position IT as a strategic
partner
Bring Emerging
Technology In
• Reframe problems
• Leverage new
technology to improve
operations
• Exploit new business
opportunities
2 3
External
Perspective
• Tech Trends
• Best practice
• Pharma and other
industries
• Potentially disruptive
developments
trends start-ups
VCs presentations
news register
showcase tools
1
scout validate
proof of concepts
3. 3
TECHNOLOGY INCUBATION LAB
Josh Mesout
Solution Engineer
Rapid Prototyping
Innovation
Data & AI
Finance & GPPS
AstraZeneca
A diverse and
multi-disciplinary team
5. 5
PROACT
Developed a mobile app to
capture patient videos and
diaries to understand drug
tolerability and potential side
effects in phase 1 clinical trials.
Developed video extraction Text
Developed facial expression Sentiment
10. 10
IOT IN SCIENCE AND MANUFACTURING
$500+ million dollar
investment
~1600 AZ & MedImmune
R&D science jobs
>12,000 Healthcare roles
working at CBC
IoT Fundamental to the running of the building
11. 11
IOT IN SCIENCE AND MANUFACTURING
Monitoring efficiency of our critical processes and
equipment
12. 12
TRANSLATE API DRIVEN
• Allows high throughput
translation
• No need to understand
source language
• 108 recognised languages
• Enterprise service, not
public so no data is retained
by Google
16. 16
AZ GENOMICS INITIATIVE
Major 10 Year program to
support precision medicine &
digital health
Combine Clinical Patient
data with Genomic data to
drive our R&D pipeline.
19. 19
FUTURE HORIZON
Developing regulatory devices for
mixed reality, super secretive
MagicLeap already have a
healthcare division and are looking
for partners
Working with Google, have
simulated a hydrogen molecule
using Quantum Computing. This
provides amazing opportunities in
optimization problems in seconds
Reduced entire infrastructure cost
by >10% using advanced neural
networks. DeepMind now working
with the NHS on differentiating
healthy and cancerous tissues
22. 22
TECHNOLOGY INNOVATION NETWORK
Technology
Innovation
Network
AZ Inspire
Network
Interaction
Network
External
Talks
AI
Network
Tech Talks
IoT
Network
Internal talks showcasing
IT innovation throughout
the company
Early Stage network
specializing in connected
devices and projects or
PoCs
Early stage network
specializing in projects that
utilize future interaction
methods
Graduate and apprentice
network giving exposure
and experience to our
most innovative generation
Early stage network
specializing in projects that
implement machine
learning or AI capabilities
Globally identifiable
companies who's
innovative approach make
them thought leaders
Recorded & Available On Nucleus Video
Monthly
Lightening
Talks (5 min)
23. 23
TECHNOLOGY INNOVATION NETWORK
23
Chris Evans
Development of a AI Chatbot
Logan King
Augmented Reality drug
adherence leaflet in
PharmTech
Frank Lombardi
Adverse events from Veeva
for Commercial using NLP
and translate
Josh Mesout
Facial sentiment
analysis using AI and
image analytics
Daniel Nunn
Swiftstack in Research
& Development
Charley Denny
AZInsight – Gamification
of Clarity forecasting
Apprentices, Interns, Students and Graduates
24. 24
TECHNOLOGY INNOVATION NETWORK
24
Neil Hardy
GCE
Commercial
SeenIT
Marie Eckerd
Clinical Ops
GMD
Trinetx
Andrew Ashall
Regulatory
GMD
Amazon Alexa
Paul Gellert
PharmDev
Ops
3D printing
Paul Harper
Discovery Sci.
IMED
Lab Robotics
Christoph Grebner
Comp. Chem
IMED
Molecular Rift
Jim Weatherall
Biometrics & Inf.
GMD
Machine Learning
Outside IT TECHTalks >50%
Jon Dry
Oncology Inf.
IMED
Healthpatch
25. Confidentiality Notice
This file is private and may contain confidential and proprietary information. If you have received this file in error, please notify us and remove
it from your system and note that you must not copy, distribute or take any action in reliance on it. Any unauthorized use or disclosure of the
contents of this file is not permitted and may be unlawful. AstraZeneca PLC, 1 Francis Crick Avenue, Cambridge Biomedical Campus,
Cambridge, CB2 0AA, UK, T: +44(0)203 749 5000, www.astrazeneca.com
25
Remember we want you to present at future TIN
sessions!
Thank You & Questions!
Steve Woodward steven.woodward@astrazeneca.com
Nick Brown nick.brown@astrazeneca.com
